Exendin‐4 protects pancreatic beta cells from human islet amyloid polypeptide‐induced cell damage: potential involvement of AKT and mitochondria biogenesis
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Aim: Glucagon‐like peptide‐1 (GLP‐1) stimulates beta‐cell proliferation and enhances beta‐cell survival, whereas oligomerization of human islet amyloid polypeptide (hIAPP) may induce beta‐cell apoptosis and reduce beta‐cell mass. Type 2 diabetes is associated with increased expression of IAPP. As GLP‐1‐based therapy is currently developed as a novel antidiabetic therapy, we examined the potential protective action of the GLP‐1 receptor agonist exendin‐4 on hIAPP‐induced beta‐cell apoptosis. Methods: The study was performed in clonal insulinoma (INS‐1E) cells. Both method of transcriptional and translational and sulphorhodamine B (SRB) assays were used to evaluate cell viability and cell mass. Western blot analysis was applied to detect protein expression. Transfection of constitutively active protein kinase B (PKB/AKT) was performed to examine the role of AKT. Mitochondrial biogenesis was quantified by mitogreen staining and RT‐PCR. Results: First, we confirmed that hIAPP induced cell apoptosis and growth inhibition in INS‐1E cells. These effects were partially protected by exendin‐4 in association with partial recovery of the hIAPP‐mediated AKT inhibition. Furthermore, AKT constitutive activation attenuated hIAPP‐induced apoptosis, whereas PI3K/AKT inhibition abrogated exendin‐4‐mediated effects. These findings suggest that the antiapoptotic and proliferative effects of exendin‐4 in hIAPP‐treated INS‐1E cells were partially mediated through AKT pathway. Moreover, hIAPP induced FOXO1 but inhibited pdx‐1 nucleus translocation. These effects were restored by exendin‐4. Finally, mitogreen staining and RT‐PCR revealed enhanced mitochondrial biogenesis by exendin‐4 treatment. Conclusions: Collectively, these results suggest that GLP‐1 receptor agonist protects beta cells from hIAPP‐induced cell death partially through the activation of AKT pathway and improved mitochondrial function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cooper, G. J., Willis, A. C., Clark, A., Turner, R. C., Sim, R. B., & Reid, K. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8628 · Cited by 1,299 · cited 1×
“The major component of amyloid is islet amyloid polypeptide (IAPP), which is a 37-amino acid protein co-secreted with insulin by the beta cells [2].”
BackgroundNauck, M. A., Kleine, N., �rskov, C., Holst, J. J., Willms, B., & Creutzfeldt, W. (1993) · Diabetologia · doi:10.1007/bf00401145 · Cited by 1,092
Thorens, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8641 · Cited by 906
Vitolo, O. V., Sant'Angelo, A., Costanzo, V., Battaglia, F., Arancio, O., & Shelanski, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172504199 · Cited by 534
Tapodi, A., Debreceni, B., Hanto, K., Bognar, Z., Wittmann, I., Gallyas, F., Varbiro, G., & Sumegi, B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507075200 · Cited by 166 · cited 1×
“In mammalian cells, AKT activity is closely correlated with mitochondrial function [38].”
BackgroundGLP-1/exendin-4 facilitates β-cell neogenesis in rat and human pancreatic ducts
Xu, G., Kaneto, H., Lopez-Avalos, M. D., Weir, G. C., & Bonner-Weir, S. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.11.007 · Cited by 115
Self-citation
Cited by
Exenatide and the treatment of patients with Parkinson's disease
Aviles-Olmos, I., Dickson, J., Kefalopoulou, Z., Djamshidian, A., Ell, P., Soderlund, T., Whitton, P., Wyse, R., Isaacs, T., Lees, A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68295 · Cited by 529
Parkinson's disease, insulin resistance and novel agents of neuroprotection
Aviles-Olmos, I., Limousin, P., Lees, A., & Foltynie, T. (2013) · Brain · doi:10.1093/brain/aws009 · Cited by 283
Reich, N., & Hölscher, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.970925 · Cited by 248
The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent
Furman, B. L. (2012) · Toxicon · doi:10.1016/j.toxicon.2010.12.016 · Cited by 166
Gao, C., Hölscher, C., Liu, Y., & Li, L. (2012) · revneuro · doi:10.1515/rns.2011.061 · Cited by 164
“The GLP-1 receptor agonist Ex-4 has also been documented in its protective effect against hAPP-induced cell death through the activation of the AKT pathway (Fan et al. , 2010 ).”
Background
Metadata
- Authors
- Fan, R., Li, X., Gu, X., Chan, J. C. N., & Xu, G.
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2010-07-23
- Volume
- 12
- Issue
- 9
- Pages
- 815-824
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W1972636432
- Cited by
- 82
- References
- 6
- FWCI
- 7.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exendin‐4 protects pancreatic beta cells from human islet amyloid polypeptide‐induced cell damage: potential involvement of AKT and mitochondria biogenesis. https://app.cochat.ai/papers/10.1111/j.1463-1326.2010.01238.x
- The paper
- Fan, R., Li, X., Gu, X., Chan, J. C. N., & Xu, G. (2010). Exendin‐4 protects pancreatic beta cells from human islet amyloid polypeptide‐induced cell damage: potential involvement of AKT and mitochondria biogenesis. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/j.1463-1326.2010.01238.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.